50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

被引:1132
|
作者
Schnabel, Renate B. [1 ,17 ]
Yin, Xiaoyan [1 ]
Gona, Philimon [1 ,11 ]
Larson, Martin G. [1 ,3 ,4 ]
Beiser, Alexa S. [1 ,3 ,8 ]
McManus, David D. [10 ]
Newton-Cheh, Christopher [1 ,13 ,14 ,15 ,16 ]
Lubitz, Steven A. [15 ]
Magnani, Jared W. [7 ]
Ellinor, Patrick T. [13 ,15 ,16 ]
Seshadri, Sudha [1 ,8 ]
Wolf, Philip A. [1 ,8 ,9 ]
Vasan, Ramachandran S. [1 ,5 ,6 ,7 ,9 ]
Benjamin, Emelia J. [1 ,2 ,6 ,7 ,9 ]
Levy, Daniel [1 ,9 ,12 ]
机构
[1] Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA
[2] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[5] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[6] Boston Univ, Sch Med, Evans Mem Med Dept, Boston, MA 02118 USA
[7] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA
[8] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[9] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA
[10] Univ Massachusetts, Sch Med, Dept Med, Div Cardiol, Boston, MA 02125 USA
[11] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Biostat & Hlth Serv Res, Boston, MA 02125 USA
[12] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA
[13] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA
[14] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA
[15] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA
[16] Broad Inst Harvard & MIT, Program Med Populat Genet, Cambridge, MA USA
[17] Deutsch Zentrum Herz Kreislauf Forsch, Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany
来源
LANCET | 2015年 / 386卷 / 9989期
关键词
LEFT-VENTRICULAR HYPERTROPHY; MEDICARE BENEFICIARIES; US; ANTICOAGULATION; HYPERTENSION; SURVIVAL; DISEASE;
D O I
10.1016/S0140-6736(14)61774-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years. Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex. Findings During 50 years of observation (202 417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20.4 to 96.2 cases per 1000 person-years in men and from 13.7 to 49.4 cases per 1000 person-years in women; age-adjusted incidence increased from 3.7 to 13.4 new cases per 1000 person-years in men and from 2.5 to 8.6 new cases per 1000 person-years in women (p(trend) < 0.0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12.6 in 1958-67 to 25.7 in 1998-2007 in men, p(trend) = 0.0007; 8.1 to 11.8 in women, p(trend) = 0.009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3.77, 95% CI 1.98-7.20 in 1958-1967 compared with 1998-2007; p(trend) = 0.0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1.34, 95% CI 0.97-1.86 in 1958-1967 compared with 1998-2007; p(trend) = 0.003) in 20 years following atrial fibrillation onset. Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.
引用
收藏
页码:154 / 162
页数:9
相关论文
共 50 条
  • [1] ATRIAL FIBRILLATION INCIDENCE, PREVALENCE, AND RISK FACTORS IN THE PRECISION TRIAL: A COHORT STUDY
    Donnellan, Eoin
    Wolski, Kathy
    Menon, Venu
    Kanj, Mohamed
    Wazni, Oussama
    Nissen, Steven
    Tarakji, Khaldoun
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 338 - 338
  • [2] Secular trends in the prevalence of atrial fibrillation: The framingham study
    Wolf, PA
    Benjamin, EJ
    Belanger, AJ
    Kannel, WB
    Levy, D
    DAgostino, RB
    [J]. AMERICAN HEART JOURNAL, 1996, 131 (04) : 790 - 795
  • [3] Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
    Vinter, Nicklas
    Huang, Qiuxi
    Fenger-Gron, Morten
    Frost, Lars
    Benjamin, Emelia J.
    Trinquart, Ludovic
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [4] Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study)
    Kim, Eun-Jeong
    Yin, Xiaoyan
    Fontes, Joao D.
    Magnani, Jared W.
    Lubitz, Steve A.
    McManus, David D.
    Seshadri, Sudha
    Vasan, Ramachandran S.
    Ellinor, Patrick T.
    Larson, Martin G.
    Benjamin, Emelia J.
    Rienstra, Michiel
    [J]. AMERICAN HEART JOURNAL, 2016, 177 : 138 - 144
  • [5] The lifetime risk of atrial fibrillation: The Framingham Heart Study
    Wang, TJ
    Larson, MG
    Lloyd-Jones, DM
    Leip, EP
    Levy, D
    Vasan, RS
    D'Agostino, RB
    Wolf, PA
    Massaro, JM
    Benjamin, EJ
    [J]. CIRCULATION, 2002, 106 (19) : 456 - 456
  • [6] Dietary factors and incident atrial fibrillation: the Framingham Heart Study
    Shen, Jian
    Johnson, Victor M.
    Sullivan, Lisa M.
    Jacques, Paul F.
    Magnani, Jared W.
    Lubitz, Steven A.
    Pandey, Shivda
    Levy, Daniel
    Vasan, Ramachandran S.
    Quatromoni, Paula A.
    Junyent, Mireia
    Ordovas, Jose M.
    Benjamin, Emelia J.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (02): : 261 - 266
  • [7] Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
    Schnabel, Renate B.
    Sullivan, Lisa M.
    Levy, Daniel
    Pencina, Michael
    Massaro, Joseph M.
    D'Agostino, Ralph B., Sr.
    Newton-Cheh, Christopher
    Yamamoto, Jennifer F.
    Magnani, Jared W.
    Tadros, Thomas M.
    Kannel, William B.
    Wang, Thomas J.
    Ellinor, Patrick T.
    Wolf, Philip A.
    Vasan, Ramachandran S.
    Benjamin, Emelia J.
    [J]. LANCET, 2009, 373 (9665): : 739 - 745
  • [8] Lifetime risk for development of atrial fibrillation - The Framingham Heart Study
    Lloyd-Jones, DM
    Wang, TJ
    Leip, EP
    Larson, MG
    Levy, D
    Vasan, RS
    D'Agostino, RB
    Massaro, JM
    Beiser, A
    Wolf, PA
    Benjamin, EJ
    [J]. CIRCULATION, 2004, 110 (09) : 1042 - 1046
  • [9] Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study
    Rahman, Faisal
    Yin, Xiaoyan
    Larson, Martin G.
    Ellinor, Patrick T.
    Lubitz, Steven A.
    Vasan, Ramachandran S.
    McManus, David D.
    Magnani, Jared W.
    Benjamin, Emelia J.
    [J]. HYPERTENSION, 2016, 68 (03) : 597 - +
  • [10] The joint influences of atrial fibrillation and heart failure on mortality: The Framingham Study
    Benjamin, EJ
    Larson, MG
    Vasan, RS
    Wolf, PA
    D'Agostino, RB
    Silbershatz, H
    Evans, JC
    Kannel, WB
    Murabito, JM
    Levy, D
    [J]. CIRCULATION, 1999, 100 (18) : 793 - 793